{{Rsnum
|rsid=11748684
|Chromosome=5
|position=42288491
|Orientation=plus
|GMAF=0.06107
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 84.8 | 14.3 | 0.9
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 79.6 | 19.7 | 0.7
| ASW | 86.0 | 14.0 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 87.1 | 12.9 | 0.0
| LWK | 75.5 | 22.7 | 1.8
| MEX | 94.8 | 5.2 | 0.0
| MKK | 85.1 | 14.3 | 0.6
| TSI | 91.0 | 9.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (docetaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=3E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}